Nan-Shan Chang

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignee: National Cheng-Kung University. Active years: 2016-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nan-Shan Chang. Retrieved from https://idiyas.com/inventor/nan-shan-chang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 (Patent Applications = 1)

% Patents Active = 33.3

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 2.5

ph-index = 1

Forward Citations = 1(Granted Patents)

Location History:

Owega, NY (US) (2016 - 2017)
Tainan, TW (2019)

Company Filing History:

3 out of 655

National Cheng-Kung University

patents

Years Active: 2016-2019

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10344065 - Method for treating Alzheimer's disease and method for downregulating protein aggregation in brain (2019-07-09),

2. 9546354 - Z cells activated by zinc finger-like protein and uses thereof in cancer treatment (2017-01-17),

3. 9375447 - Modified hyaluronan and uses thereof in cancer treatment (2016-06-28),

Title: The Innovative Contributions of Nan-Shan Chang

Introduction

Nan-Shan Chang is a notable inventor based in Owega, NY (US). He has made significant contributions to the field of medical research, particularly in the treatment of Alzheimer's disease and cancer. With a total of 3 patents, his work has the potential to impact many lives.

Latest Patents

Chang's latest patents include a method for treating Alzheimer's disease and a method for downregulating protein aggregation in the brain. This innovative approach involves administering a zinc finger-like peptide to a subject in need, where the peptide comprises an amino acid sequence of RRSSSCK (SEQ ID NO: 1). Additionally, he has developed immune cells (Z cells) activated by zinc finger-like protein that regulates apoptosis (Zfra) and explores their uses in cancer treatment.

Career Highlights

Throughout his career, Nan-Shan Chang has worked with esteemed institutions, including National Cheng-Kung University. His research has focused on groundbreaking methods that address critical health issues, showcasing his dedication to advancing medical science.

Collaborations

Chang has collaborated with notable coworkers such as Wan-Pei Su and Yu-An Chen, contributing to a rich environment of innovation and research.

Conclusion

Nan-Shan Chang's work exemplifies the spirit of innovation in the medical field. His patents and research efforts are paving the way for new treatments that could significantly improve patient outcomes.

Profile summary based on public USPTO records.